>
MustGrow Biologics logo

MGRO - MustGrow Biologics Share Price

C$1.92 -0.0  -1.0%

Last Trade - 16/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £47.5m
Enterprise Value £46.5m
Revenue £n/a
Position in Universe 946th / 2713
Bullish
Bearish
Unlock MGRO Revenue
Momentum
Relative Strength (%)
1m -4.01%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -15.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.11 0.002 0.002 0.000 -100.0%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,MustGrow Biologics Corp revenues was not reported. Net lossincreased from C$1M to C$2.4M. Higher net loss reflectsCorporate communications increase from C$112K to C$862K(expense), Stock-Based Compensation increase from C$87K toC$623K (expense), Marketing and promotion increase fromC$19K to C$210K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for MGRO
Graphical History

Revenue

MGRO Revenue Unlock MGRO Revenue

Net Income

MGRO Net Income Unlock MGRO Revenue

Normalised EPS

MGRO Normalised EPS Unlock MGRO Revenue

PE Ratio Range

MGRO PE Ratio Range Unlock MGRO Revenue

Dividend Yield Range

MGRO Dividend Yield Range Unlock MGRO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MGRO EPS Forecasts Unlock MGRO Revenue
Profile Summary

MustGrow Biologics Corp. is a Canada-based agricultural company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry. Targeting the fruit, vegetable, turf, ornamentals and cannabis industries, the Company has designed a solution that uses the mustard seed’s natural defense mechanisms to protect plants from pests and diseases.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated December 2, 2014
Public Since July 10, 2019
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Canadian Securities Exchange
Shares in Issue 42,755,496
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MGRO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MGRO
Upcoming Events for MGRO
Frequently Asked Questions for MustGrow Biologics
What is the MustGrow Biologics share price?

As of 16/04/21, shares in MustGrow Biologics are trading at C$1.92, giving the company a market capitalisation of £47.5m. This share price information is delayed by 15 minutes.

How has the MustGrow Biologics share price performed this year?

Shares in MustGrow Biologics are currently trading at C$1.92 and the price has moved by 0.482k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the MustGrow Biologics price has moved by 0.332k% over the past year.

What are the analyst and broker recommendations for MustGrow Biologics?

There are no analysts currently covering MustGrow Biologics.

When will MustGrow Biologics next release its financial results?

MustGrow Biologics is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the MustGrow Biologics dividend yield?

MustGrow Biologics does not currently pay a dividend.

Does MustGrow Biologics pay a dividend?

MustGrow Biologics does not currently pay a dividend.

When does MustGrow Biologics next pay dividends?

MustGrow Biologics does not currently pay a dividend.

How do I buy MustGrow Biologics shares?

To buy shares in MustGrow Biologics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of MustGrow Biologics?

Shares in MustGrow Biologics are currently trading at C$1.92, giving the company a market capitalisation of £47.5m.

Where are MustGrow Biologics shares listed? Where are MustGrow Biologics shares listed?

Here are the trading details for MustGrow Biologics:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: MGRO
What kind of share is MustGrow Biologics?

Based on an overall assessment of its quality, value and momentum, MustGrow Biologics is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a MustGrow Biologics share price forecast 2021?

We were not able to load any forecast data for MustGrow Biologics.

How can I tell whether the MustGrow Biologics share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MustGrow Biologics. Over the past six months, the relative strength of its shares against the market has been 0.304k%. At the current price of C$1.92, shares in MustGrow Biologics are trading at 90.11% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the MustGrow Biologics PE Ratio?

We were not able to find PE ratio data for MustGrow Biologics.

Who are the key directors of MustGrow Biologics?

MustGrow Biologics's management team is headed by:

Corey Giasson - PRE
Todd Lahti - CFO
Colin Bletsky - COO
Brad Munro - NEC
Thomas Flow - IND
Matt Kowalski - IND
Brian Quigley - IND
David Borecky - DRC
Who are the major shareholders of MustGrow Biologics?

Here are the top five shareholders of MustGrow Biologics based on the size of their shareholding:

Bletsky (Colin Michael) Individual Investor
Percentage owned: 3.14% (1.34m shares)
Giasson (Corey J) Individual Investor
Percentage owned: 2.7% (1.15m shares)
Munro (Bradley R) Individual Investor
Percentage owned: 2% (856k shares)
Quigley Brian W Individual Investor
Percentage owned: 0.67% (286k shares)
Flow (Thomas) Individual Investor
Percentage owned: 0.43% (185k shares)
Similar to MGRO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.